Skip to main content

CORRECTION: C-RAD AB: Interim report 1 January – 30 June 2012

Correction: bullits, key events after end of period
Interim report 1 January-30 June 2012

Correction: bullits, key events after end of period

Interim report 1 January-30 June 2012

C-RAD AB (publ)

Key events during the period

  • Sales for the period were 9,7 SEK ( 7,9 MSEK)
  • EBITA of -12,4 MSEK (-13,5 MSEK)
  • Loss after tax of -12,7 MSEK (- 13,7 MSEK)
  • An order back log of 16,7 (6,2) MSEK
  • Bookings for the period were 14,4 MSEK ( 9,2 MSEK)
  • Earnings per share after tax of -0,80 SEK (- 1,12 SEK)
  • Equity ratio of 57 % (68 %)
  • Cash of 10 596 kSEK (4 110 kSEK)
  • Numbers of employees were 21 (21)
  • IBA Dosimetry has for 2012 placed a frame order of 6, 1 MSEK. Due to quality problems at suppliers deliveries have been postponed until second half of the year.
  • A breakthrough for C-RAD on key markets
  • C-RAD has received FDA clearance for its new Catalyst system
  • Interfaces for communication with Varian accelerators have been released
  • The C-RAD Sentinel system is available with interfaces to three major CT vendors
  • Successful presentations of the C-RAD program at European conferences
  • An agreement has been signed with Elekta within the field of respiratory gating
  • New sales offices and subsidiaries founded in Berlin and Shanghai
  • Agreement has been signed with Erik Penser Bank Aktiebolag.


Key events after the close of the reporting period

  • Two new orders of C-RAD Sentinel from Elekta in China
  • Approved US patent for the C-RAD inter active technology
  • First installation in Germany of the Catalyst system equipped with respiratory gating integrated with a Varian Unique system
  • FDA clearance of the C-RAD Sentinel with functionality for 4DCT
  • A great interest for C-RAD solutions at AAPM in the US



Comments by Erik Hedlund, president of C-RAD AB.

“In spite of distribution problems in the US and quality problems with components for the diode detector production bookings and sales increased with 56% and 23% respectively compared to last year.

Results from the startup of C-RAD sales companies in Germany, China and the US and direct sales in Scandinavia can already be seen. The effects however will be obvious in Q3 and Q4.

Until end of the year a strong development is expected.”



For further information:

Erik Hedlund, CEO C-RAD AB, Phone +46-(0)18-66 69 31, E-Mail


Close Menu